| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3402556 | Enfermedades Infecciosas y Microbiología Clínica | 2008 | 6 Pages |
Abstract
No differences in the sustained virological or biochemical response were found between groups receiving peginterferon alfa-2a or peginterferon alfa-2b plus ribavirin, suggesting that the two types of peginterferon alfa are similarly effective for treating hepatitis C in monoinfected patients.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
Juan Francisco Márquez-Peiró, Victoria Eugeni Valero-Alcocer, MarÃa Manuela del Mar Morales-Suárez-Varela, AgustÃn Llopis-González, Carmen Pérez-Peiró,